Indonesia keeps building shiny technoparks to celebrate innovation, but until its institutions actually reward risk and ...
Stainless, a New York-based startup, founded in 2022, rose to prominence in the emerging AI industry for automating the ...
Learn how a single JavaScript Date() timezone mistake silently corrupts web apps and how to fix timestamp bugs in JS, Python, ...
President Prabowo Subianto said downstreaming is key to Indonesia’s economic growth and energy self-sufficiency, as the government seeks to capture more ...
Hosted on MSN
Level up your Minecraft modding skills today
Minecraft modding is more accessible than ever, with tools and guides for every skill level. Whether you’re coding in Java, using drag-and-drop builders, or leveraging AI, you can bring your ideas to ...
TALLINN, Estonia, April 21, 2026 /PRNewswire-PRWeb/ -- OKRs Tool, a goal-setting platform built for growing teams, today released The ROI of OKRs: 2026 Benchmark Report, the first study to quantify ...
On March 19, 2026, FERC approved Southwest Power Pool, Inc.’s (SPP) System Support Resource (SSR) program to allow SPP, under specified conditions, to keep certain generating units that plan to retire ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...
March 10 (Reuters) - OpenAI plans to soon launch its AI video generator Sora in ChatGPT, The Information reported on Tuesday, citing people familiar with the matter. Sign up here. While text-centric ...
Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results